Biosynex SA (EPA:ALBIO)
France · Delayed Price · Currency is EUR 0.8860
-0.0040 (-0.45%)
Jun 19, 2026, 5:35 PM CET
Biosynex Market Cap
Biosynex has a market cap or net worth of €16.33 million as of June 18, 2026. Its market cap has decreased by -33.76% in one year.
Market Cap
16.33M
Enterprise Value
69.52M
Revenue
95.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.89
Market Cap Chart
Since March 25, 2011, Biosynex's market cap has increased from 8.12M to 16.33M, an increase of 101.06%. That is a compound annual growth rate of 4.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 16.33M | 46.15% |
| Dec 31, 2025 | 11.17M | -39.63% |
| Dec 31, 2024 | 18.51M | -78.44% |
| Dec 29, 2023 | 85.85M | -39.13% |
| Dec 30, 2022 | 141.04M | -51.35% |
| Dec 31, 2021 | 289.89M | 91.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Carvolix | 214.46M |
| Median Technologies | 199.98M |
| Guerbet | 119.34M |
| Theraclion | 56.07M |
| Diagnostic Medical Systems | 33.17M |
| Mauna Kea Technologies | 29.74M |
| Novacyt | 29.56M |
| Implanet | 26.58M |